Mounjaro can help with weight loss if you have polycystic ovary syndrome (PCOS), but its effects on symptoms such as irregular periods and fertility are still unclear. As a pharmacist, my advice is not to assume that weight loss will improve every symptom. If you are considering Mounjaro, it is worth understanding what it can realistically do and where the evidence is still limited. You may also come across the term polyendocrine metabolic ovarian syndrome (PMOS), but I have used PCOS throughout this article as it remains the term most people search for. 

Does Mounjaro Help With PCOS?

Mounjaro can help adults lose weight, which may be useful when managing PCOS. A 2026 UK study involving 54,114 women prescribed tirzepatide found that those who reported having PCOS lost weight at a similar rate to women without the condition. 

However, the study did not look at changes in periods, hormone levels or fertility. The authors also work for the service involved in the study and describe the evidence for tirzepatide in PCOS as markedly limited. 

Mounjaro works by acting on appetite and helping you feel fuller for longer. PCOS is more complicated than weight alone, as the NHS explains that hormones such as insulin and testosterone may not work as they should. So, while weight loss may be one part of managing PCOS, Mounjaro is not a treatment for the condition itself. 

Is Mounjaro Licensed Or Prescribed For PCOS?

No, Mounjaro is not licensed specifically to treat PCOS. The MHRA lists its uses as type 2 diabetes and weight management in adults. A prescriber may consider it if you meet the weight management criteria in the product information, but that does not mean it treats PCOS directly. 

The 2023 international PCOS guideline says weight loss medicines may be considered alongside lifestyle support for people with a higher weight. However, their use to improve reproductive outcomes should be limited to research settings. 

Can Mounjaro Help With Insulin Resistance And Irregular Periods?

The NHS notes that blood tests can check hormone levels and insulin resistance. Weight loss often improves insulin sensitivity, and a 2026 review of randomised trials found improved insulin resistance with GLP-1 medicines in PCOS. The certainty was moderate for BMI and insulin resistance, and very low for testosterone. Most trials used older medicines, so tirzepatide itself is less studied. A review informing the guideline called published data very limited. 

For irregular periods, I would not rely on Mounjaro. Weight loss may restore ovulation for some women, but there is no tirzepatide trial proving it. The NHS suggests the combined pill, the progestogen-only pill or an intrauterine system. Our guides on Mounjaro and your period and irregular cycles may help. 

Does Mounjaro Affect PCOS Symptoms Beyond Weight Loss?

Not reliably, because the evidence does not yet show how tirzepatide affects periods, acne, excess hair growth or fertility in PCOS. The NHS lists separate treatments for each of these, so please do not assume weight loss will improve every symptom. If your weight changes but they persist, my advice is to speak to your clinician about whether your PCOS plan needs adjusting. 

Can I Get Pregnant On Mounjaro With PCOS?

Yes, you still can, so please do not assume irregular periods mean you are protected. The NHS explains that PCOS can stop the ovaries releasing an egg each month. Weight loss may restore ovulation for some women, so protection cannot be assumed. The MHRA advises that anyone who could become pregnant should avoid pregnancy while using these medicines. 

  • Use reliable contraception throughout treatment. 
  • If you take the contraceptive pill, use an additional barrier method for four weeks after starting Mounjaro and for four weeks after every dose increase. Alternatively, discuss switching to a non-oral method with your healthcare professional. Our guide to Mounjaro and the contraceptive pill explains this in more detail. 
  • If you are planning a pregnancy, stop at least 1 month before trying to get pregnant, in consultation with your prescriber. 

Is Mounjaro Safe For PCOS, And What Else Can Help?

Mounjaro suits some people and not others, so it needs a clinical assessment. The product information says stomach effects such as nausea, vomiting and diarrhoea are mostly mild or moderate and occur mainly while the dose rises. Hair loss was reported more often than with placebo, which matters if PCOS already affects your hair. Gallbladder problems were also linked with weight reduction in trials. Severe, persistent stomach pain needs urgent medical help. 

The NHS says PCOS cannot be cured, but treatments help. Alongside lifestyle changes, it lists metformin, hormonal contraception, clomifene for fertility and hair treatments such as spironolactone. Our guide on managing hirsutism with PCOS covers one common concern. 

How Do I Talk To A Clinician About Mounjaro And PCOS?

Before discussing Mounjaro, it is worth thinking about what you want from your treatment to achieve. Are you mainly concerned about weight, irregular periods, unwanted hair growth or future pregnancy plans? These details can help your clinician decide which options are appropriate. 

I would recommend taking the following information to your appointment: 

  • Your PCOS diagnosis and the symptoms you experience. 
  • Details of your menstrual cycle and any plans to become pregnant. 
  • A list of your current medicines, including metformin and hormonal contraception. 

You can then start your consultation with Pharmacy Planet. A UK clinician will review your health information and decide whether treatment is clinically appropriate or whether another option would be more suitable. 

Frequently Asked Questions

Can Mounjaro Cure PCOS?

No. The NHS says there is no cure for PCOS. Treatments and lifestyle changes manage symptoms, and Mounjaro is not licensed for the condition. 

Can I Take Mounjaro With Metformin For PCOS?

The Mounjaro product information says that when tirzepatide is added to existing metformin, the current metformin dose can be continued. Please do not stop or start metformin yourself. Your prescriber decides. 

Is Mounjaro Better Than Metformin For PCOS?

Nobody can say for certain, because I am not aware of trials comparing tirzepatide with metformin in PCOS. The NHS lists metformin as a treatment option, and it works differently. 

How Long After Stopping Mounjaro Can I Try For A Baby?

The MHRA advises stopping tirzepatide at least one month before trying to conceive. Please speak to your prescriber first. 

Can I Get Mounjaro On The NHS For PCOS?

NICE recommends tirzepatide on the NHS only with a BMI of at least 35 and at least one weight-related condition, with lower BMI thresholds for some ethnic backgrounds. Your GP can tell you whether you qualify, and local access varies. 

Why Is Weight Loss Harder With PCOS?

The cause of PCOS is unknown, but the NHS says insulin and testosterone may not be working properly, and difficulty losing weight is a recognised symptom. That is not a failure of willpower. 

Is PCOS Now Called PMOS?

Yes. A global consensus in The Lancet in May 2026 renamed it polyendocrine metabolic ovarian syndrome, with a three-year transition. The NHS already uses PMOS. 

This article is for general information and is not medical advice. Mounjaro is a prescription-only medicine, is not licensed to treat PCOS and is supplied only after a clinical assessment. Do not start, stop or change any medicine for PCOS without speaking to your prescriber. If you have severe or persistent stomach pain, seek urgent medical help. 

Sources Referenced

  1. NHS, Polyendocrine metabolic ovarian syndrome (PMOS) (previously called PCOS), last reviewed 30 June 2026 
  2. The Lancet, Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process (published online 12 May 2026; 2026;407(10545):2329 to 2339) 
  3. MHRA, GLP-1 medicines for weight loss and diabetes: what you need to know (updated 5 February 2026), sections on licensed uses, contraception and pregnancy 
  4. electronic medicines compendium, Mounjaro KwikPen Summary of Product Characteristics (updated 8 September 2026), sections 4.1, 4.2, 4.8 and 5.1 
  5. NICE, Tirzepatide for managing overweight and obesity, TA1026, recommendations 
  6. Clift AK, Reisel D, Johnson H, Sattar N, Huang DR, Weight loss outcomes with tirzepatide in women with and without self-reported polycystic ovary syndrome, Journal of the Endocrine Society 2026;10(9):bvag177 
  7. Teede HJ, et al., Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Fertility and Sterility 2023;120(4):767 to 793 
  8. Goldberg A, et al., Anti-obesity pharmacological agents for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 international evidence-based guideline, Obesity Reviews 2024;25(5):e13704 
  9. Effectiveness of GLP-1 receptor agonists in patients with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials, 2026